Australia, March 19 -- Entera Bio Ltd., owns the trademark (2509991) for 'N-TAB' till Aug. 15, 2034.
Status: protected:
Registered/protected
Classes: 5 [Pharmaceutical preparations, namely, a drug delivery formulation that enables oral delivery of proteins and peptides; pharmaceutical preparations for use as peptide replacement therapy; pharmaceutical preparations for the treatment of osteoporosis; pharmaceutical preparations for the treatment of hypoparathyroidism; pharmaceutical preparations for the treatment of obesity; pharmaceutical preparations for the treatment of metabolic conditions; pharmaceutical preparations for the treatment of short bowel syndrome; pharmaceutical preparations for the treatment of stress fractures; drug deliv...